Gain Therapeutics Inc. (GANX)
1.61
-0.18 (-10.06%)
At close: Apr 04, 2025, 3:49 PM
Gain Therapeutics Stock Forecast
Stock Price Forecast
The 5 analysts with 12-month price forecasts for GANX stock have an median target of 7.5, with a low estimate of 6 and a high estimate of 8. The median target predicts an increase of 365.84% from the current stock price of 1.61.
Latest Analyst Insight Report
Chardan Capital has reaffirmed a Buy rating on Gai... Unlock content with Pro Subscription
Updated Mar 28, 2025
Financial Forecast this Year
Revenue This Year
40K
from 0
Increased by -%
Revenue Next Year
225K
from 40K
Increased by 462.5%
EPS This Year
-0.73
from -0.89
Increased by 18.0%
EPS Next Year
-0.89
from -0.73
Increased by -21.9%